Paragon 28 Revenue 2020-2022 | FNA

Paragon 28 revenue from 2020 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Paragon 28 Annual Revenue
(Millions of US $)
2021 $147
2020 $111
2019 $106
Paragon 28 Quarterly Revenue
(Millions of US $)
2022-06-30 $42
2022-03-31 $41
2021-12-31 $43
2021-09-30 $36
2021-06-30 $36
2021-03-31 $33
2020-12-31
2020-09-30 $30
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.568B $0.147B
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $236.833B 24.12
Edwards Lifesciences (EW) United States $64.933B 45.94
Alcon (ALC) Switzerland $34.110B 28.88
STERIS (STE) Ireland $21.399B 26.58
Teleflex (TFX) United States $11.944B 19.03
Fresenius Medical Care AG KGaA (FMS) Germany $10.930B 10.08
Globus Medical (GMED) United States $6.721B 34.28
Penumbra (PEN) United States $6.619B 794.04
Integer Holdings (ITGR) United States $2.525B 19.75
Glaukos (GKOS) United States $2.496B 0.00
Nevro (NVRO) United States $1.877B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.400B 21.44
Artivion (AORT) United States $0.937B 89.42